CorMedix Inc.

NasdaqGM CRMD

CorMedix Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2024: 83.54%

CorMedix Inc. Gross Profit Margin is 83.54% for the Trailing 12 Months (TTM) ending September 30, 2024, a 120.21% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

CorMedix Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -413.30%, a -1,033.73% change year over year.
CorMedix Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was 44.26%, a 162.43% change year over year.
CorMedix Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 16.87%, a 141.34% change year over year.
CorMedix Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was 6.99%, a 131.02% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

NasdaqGM: CRMD

CorMedix Inc.

CEO	Mr. Joseph Todisco MBA
IPO Date	May 13, 2010
Location	United States
Headquarters	300 Connell Drive
Employees	82
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Key trends

Past 5 years